Omaha, NE, United States of America

Anish Vadukoot

This inventor holds 1 USPTO granted patent. Top assignees: La Jolla Pharmaceuticals Company, Vanderbilt University. Active years: 2020.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anish Vadukoot: Innovator in BMP Signaling Inhibition

Introduction

Anish Vadukoot is a notable inventor based in Omaha, NE (US). He has made significant contributions to the field of biomedical research, particularly in the area of BMP signaling inhibition. His work has implications for various medical applications, showcasing his innovative approach to solving complex biological problems.

Latest Patents

Vadukoot holds a patent titled "Inhibition of BMP signaling, compounds, compositions and uses thereof." This patent includes substituted imidazo[1,2-a]pyridines that are useful as inhibitors of BMP signaling. The invention also encompasses pharmaceutical compositions of these compounds and outlines their medical uses. He has 1 patent to his name, reflecting his commitment to advancing scientific knowledge.

Career Highlights

Throughout his career, Anish Vadukoot has worked with prestigious institutions, including Vanderbilt University and La Jolla Pharmaceuticals Company. His experiences in these organizations have allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Darren W Engers and Corey R Hopkins. Their collaborative efforts have further enriched the research environment and fostered innovation in their respective fields.

Conclusion

Anish Vadukoot's contributions to BMP signaling inhibition exemplify the impact of innovative thinking in biomedical research. His patent and collaborations highlight the importance of teamwork in advancing scientific discovery.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…